Search | IOVS | ARVO Journals

View

Showing 1 – 7 of 7

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2009

C- Reactive Protein Levels in Pseudoexfoliative Patients Serum and Aqueous Humor

O. H. Cuello; J. C. Muiño; J. P. Pusterla; S. F. Lerner; A. L. Gramajo; J. D. Luna; C. P. Juarez

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5841. doi:

ARVO Annual Meeting Abstract April 2009

Ocular Toxicity of Intravitreous Omalizumab (Xolair) in the Rabbit

C. P. Juarez; G. A. Colombres; J. P. Pusterla; L. G. Garcia; J. C. Muiño; J. D. Luna

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5986. doi:

ARVO Annual Meeting Abstract May 2007

Disease Progression Markers in Uveitis: The Importance of Autoantibodies to Retinal S Antigen to Galectine-1, and Slpi Serum Levels

C. P. Juarez; J. C. Muiño; M. Romero; M. Ferrero; G. Rabinovich; J. D. Luna

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):5184. doi:

ARVO Annual Meeting Abstract May 2007

Anti-Galectin-1 Antibodies in Patients With Pars Planitis

J. D. Luna Pinto; J. C. Muiño; M. Romero; M. Ferrero; G. Ravinovich; C. P. Juarez

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):5186. doi:

ARVO Annual Meeting Abstract May 2006

Circulating Anti–Galectin–1 Antibodies Are Associated With the Severity of Ocular Disease in Autoimmune and Infectious Uveitis

C.P. Juarez; M.D. Romero; J.C. Muiño; G.A. Bianco; M. Ferrero; G.A. Rabinovich; J.D. Luna

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3513. doi:

ARVO Annual Meeting Abstract May 2005

Presence of Serum Leukocyte Protease Inhibitor in Patients With Uveitis

C.P. Juarez; V.E. Reviglio; M.D. Romero; M. Ferrero; J.D. Luna; J. Muiño

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5123. doi:

ARVO Annual Meeting Abstract May 2004

Specific human IgG and IgE response to corneal antigens following Lasik

C.P. Juarez; V.E. Reviglio; C. Raffaini; M. Romero–Piffiguer; M. Ferrero; J.D. Luna; J.C. Muiño

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):623. doi:

Advertisement